ImmunoGen (IMGN) plummets on MARIANNE news

ImmunoGen, Inc. (NASDAQ: IMGN) shares dropped 43.5% to $6.13 after the company reported that Roche has provided an update on the MARIANNE trial. Share volume totaled 7.3 million, or six times its all-day average